Denture-associated stomatitis (DS) affects over two-thirds of denture-wearers. DS presents as erythema of the palatal mucosa in areas where denture-surface associated polymicrobial biofilms containing the fungus Candida albicans exist. The contribution of the oral bacterial microbiota toward the infection is unknown. Therefore, this study characterised the bacterial microbiota of sites within the oral cavity to identify potential associations with occurrence of DS. Denture-wearing patients were recruited (denture stomatitis (Ds) n = 8; non-denture stomatitis (NoDS) n = 11) and the oral bacterial microbiota of the tongue, palate and denture-fitting surface was characterised using next-generation sequencing. Operational taxonomic units (OTUs) were identified to bacterial genera and species, and presence/absence and relative abundances were examined. A significant (P = 0.007) decrease in the number of OTUs and thus, diversity of the microbiota was observed in tongue samples of DS patients (vs non-DS). The microbiota of denture-fitting surfaces and palatal mucosae were similar. Large differences in the abundance of bacterial genera and species were observed at each sample site, and unique presence/absence of bacteria was noted. Presence/absence and relative abundance of specific bacteria associated with DS warrants further in vitro and in vivo evaluation, particularly as our previous work has shown C. albicans virulence factor modulation by oral bacteria.
The microbiota of higher organisms, and particularly humans, are of great interest given their affiliation with homeostasis of the host and normal function of many different body sites. There is substantial interest in the onset of disease that may be attributed to the endogenous microbiota, fuelled by the view that whilst these communities exist naturally at sites in the human body without negative impact toward the host, changes in the composition of the microbiota can lead to dysbiosis and development of localised and systemic infection.
Microbial communities are crucial to the normal function of many different environments in the human body, such as the gastrointestinal tract 1, 2 where microbial communities contribute to food breakdown, providing nutrients to surrounding host cells, thus developing a mutually beneficial relationship between the host and the resident microbiota. However, this benefit is not always maintained. Factors including the use of antibiotics, or significant changes in diet can lead to altered proportions of microorganisms in the gut microbiota, leading to dysbiosis and potential infection [3] [4] [5] . Dysbiosis also applies to the oral cavity, where even subtle changes can lead to disease. This is evident in dental caries and periodontal disease, where an increase in the proportion of known 'keystone' pathogens, including Streptococcus mutans or Porphyromonas gingivalis, leads to substantial destruction of enamel and surrounding tissue, respectively [6] [7] [8] [9] [10] . Various microenvironments exist within the oral cavity, offering a number of unique surfaces for microbial colonisation e.g. hard tooth enamel surfaces and soft tissues. Each location supports a distinct microbiota, arising from, among other factors, the diverse environmental conditions, physical environment and nutrient availability. The resident oral microbiota can inhibit the development of diseases including dental caries 11 by minimising levels of potentially pathogenic microorganisms 10, 12 , through direct competition for colonisation and/or nutrients 13 .
Several studies have characterised the healthy bacterial microbiota at different sites in the oral cavity, including tooth surfaces, oral mucosae and saliva 9, 12, 14 , and The Human Oral Microbiome Database (HOMD), established in 2010, indicates that over 700 bacterial species exist in the mouth 15 . In addition to bacteria within the oral microbiota, fungi play an increasingly acknowledged role in the onset of disease. Oral candidosis, for example, is one such frequently occurring, but somewhat underappreciated infection. Candida albicans remains the most frequent Candida species isolated from the oral cavity and is widely regarded as the primary cause of chronic erythematous candidosis (also known as denture-associated stomatitis; DS). DS affects approximately 67% of denture wearers 16 , presenting as erythema of the palatal mucosa in areas that are in direct contact with the fitting-surface of a complete or partial denture. The extent of inflammation can be categorised according to Newton's classification 17 : Type 0, no erythema; Type 1, localised, pinpoint erythema; Type 2, diffuse erythema (moderately red, covering part or all of the area of denture contact); Type 3, hyperplastic granular inflammation (severely red or swollen palatal mucosa) [18] [19] [20] . Although it is recognised that C. albicans is the primary causative microorganism of DS, several predisposing factors known to promote the condition have been documented including tobacco use, nocturnal denture wearing, ill-fitting dentures, and poor oral and denture hygiene. However, our knowledge of the role of the bacterial microbiota and the contribution toward DS is poor. C. albicans is described as an opportunistic pathogen, with the ability to exist in a commensal yeast-like form, and can undergo a morphogenic transition to elongated hyphae, considered the pathogenic form 21 . Previously, we have shown that biofilms containing oral bacteria and C. albicans result in significantly greater tissue damage and an increased immune response relative to C. albicans-only biofilms 22, 23 . Furthermore, in these previous studies, C. albicans hyphae, and the expression of a range of virulence factors including hydrolytic enzymes, were shown to increase when C. albicans was cultured with oral bacteria in mixed-species biofilms. We have also found that the inclusion of other oral bacteria, albeit another keystone pathogen (Porphyromonas gingivalis), in mixed-species biofilms can further modulate the virulence of C. albicans, leading to reduced C. albicans virulence 24 .
As a result of these in vitro findings, the aim of this study was to characterise the bacterial microbiota at three oral sites (tongue, hard palate, and fitting-surface of the denture) in patients with and without clinical signs of DS, to further our understanding of the potential involvement of oral bacteria in DS.
Results

Patient demographics.
A total of 19 patients were recruited to the study (denture stomatitis (DS) n = 8; non-denture stomatitis (NoDS) n = 11). The demographic and clinical data for the subjects are presented in Table 1 . Samples were assigned an anonymised reference number (S001-S019). The sample ID included reference to the sample site; where T referred to tongue, P to palatal mucosa, and D was the denture-fitting surface (e.g. S001T, patient 1 tongue sample site).
More females (n = 11) were recruited than males (n = 8), and similar average ages 69.64 years (±13.84) and 64.88 years (±7.14) were evident for both genders, respectively. Of the recruited patients, eight (42.1%) were current smokers.
Eight patients had DS to varying extent (Female n = 6; Male n = 2), whereas 11 individuals had no signs of DS (Female n = 5; Male n = 6). Several samples that did not yield Candida growth by agar culture did test positive for Candida by the nested PCR method. These samples were S003D, S006P, S006D, S007T, S007D, S008T, S008P, S013D, S014P, S015D. In these sample descriptions, D, P and T represent denture, palate and tongue, respectively. Conversely, Candida was not detected by molecular testing of the S014T sample but was detected by culture.
From each sample type (i.e. tongue, palate or denture) on SDA, several typical colonies were subcultured on to CHROMagar ® Candida agar. The agar plates were incubated for 48 h, after which, a turquoise/green colour was observed for colonies, indicating presumptive identification of C. albicans. Nested real-time PCR was used to identify Candida in samples to species level. Amplicons were observed in the pan-Candida channel for numerous samples, but no detection was evident in the C. glabrata or C. krusei probe channels, thus eliminating the presence of these species. These results, when considered alongside those of culture, indicated the presence of Candida, presumably C. albicans, in all tested samples, and subsequent germ tube tests confirmed the ability of isolates to form hyphae in the presence of serum.
Metataxonomic profiling of bacterial species present in swab samples. Of the 57 samples collected, 55 were processed for DNA sequencing. Five failed to yield amplicons in the primary stage, thus the remaining 50 samples were used in subsequent analyses. A total of 2,194,967 sequence reads were obtained, and after quality control steps, the total number of final reads was 1,864,575. To normalise between samples, the OTUs were sub-sampled to the lowest read count (S019P) of 10,995 reads.
Patients were grouped by disease status i.e. presence or absence of clinical symptoms of DS (DS or NoDS, respectively), and analysed. In total, 2,411 OTUs were identified, 353 of which had more than ten sequence reads. Bacterial genera and species with ten or more sequence reads were included in analysis.
Duplicate bacterial species (which can arise due to strain sequence variation) when phylotypically classified were merged, along with their OTU and relative proportion data. Thus, the overall number of unique bacterial species was lower than the number of OTUs detected. Both were considered independently for the purpose of this study.
Differences in bacterial microbiota of DS and Non-DS patients. Quantities and relative proportions
of bacterial genera were compared within sample sites (e.g. DS versus NoDS in samples of the tongue, palate and denture-fitting surface), and between sample sites, e.g. (Tongue DS versus Palate DS versus Denture DS). No significant (P > 0.05) differences were evident when comparing within or between sample sites for the number www.nature.com/scientificreports www.nature.com/scientificreports/ of genera when considering patients grouped by disease state and sample site (Fig. 1A) . Similarly, no significant (P = 0.191) differences were evident when analysing patients grouped by disease status only (Fig. 1B) .
The number of unique OTUs was determined for each sample (Chao index) (Fig. 2 ). The number of unique OTUs in samples of the denture-fitting surface ( Fig. 2A) showed no significant differences (P = 0.806) between DS and NoDS patients. Similarly, samples from the palatal mucosa (Fig. 2B ) in the same patients showed a slight increase in the number of unique bacterial species for NoDS patients, but this was not statistically significant (P = 0.104). However, a significant (P = 0.007) increase in the number of unique bacterial species was observed in samples from the tongue (Fig. 2C ) of NoDS compared with DS patients.
The Shannon index was calculated (Fig. 3) as an indication of OTU abundance and evenness of spread, to indicate diversity within the samples. No significant differences (P > 0.05) were observed between DS and NoDS patients for any sample site. This was indicative that the frequency of OTUs was more evenly distributed across the whole population, rather than clusters of higher relative abundance associated with a smaller group of specific bacterial species. A slightly higher Shannon index was observed for NoDS samples from the palatal mucosa than DS samples, indicating that differences in the evenness of distribution between the frequency of bacterial species may have been present, but the differences were subtle and not significant.
Communities of microorganisms can be grouped by overall similarities of the bacterial microbiota and presented graphically to show whether or not the clusters are distinct. Where clusters of samples overlap, they are deemed not dissimilar. Non-metric multidimensional scaling plots were generated for each sample site (Fig. 4) . The spread of the data points and the trends indicated by the ellipses of the patient groupings of DS and NoDS patients overlapped considerably in this analysis for all sample sites. This indicated the bacterial microbiota as a whole were not considered distinct, but as such showed greater overall similarities between the healthy and disease states. The spread within the results indicated some variation between samples, and inherent variability between patients.
Presence and differences in relative abundance of bacteria analysed at genera and species level.
Despite no differences in the genera-associated microbiota being evident when considered collectively (Fig. 5) , when analysing relative abundance differences between DS and NoDS at each sample site, some striking differences were detected. Data presented in Fig. 5 (with corresponding specific numerical proportions presented in Supplementary Tables S1-S3) demonstrate the proportion of each detected genera as a mean value of all the participants in that sample group, where many substantial differences were observed. In samples of the denture-fitting surface (Fig. 5A,B) , a number of shifts were observed, particularly in the genera associated with the top 15 genera by mean abundance. In DS-associated samples, increases in the relative abundance of www.nature.com/scientificreports www.nature.com/scientificreports/ Streptococcus, Pseudomonas, and Stenotrophomonas were evident, with decreases in the relative abundance of Actinomyces, Serratia, and Rhizobium.
Shifts in relative abundances of genera were also observed in samples of other sites, including large increases in relative abundances observed in Streptococcus, Masillia and Acinetobacter in samples of the palate (Fig. 5C,D) , and Streptococcus and Enterococcus in samples of the tongue (Fig. 5E,F) . Large decreases in genera including Serratia, Lactobacillus and Flavobacterium were evident in samples of the palate, and similarly, decreases in Serratia and Flavobacterium were observed in samples of the tongue.
When considering the microbiota at species level, the relative proportion of different bacterial species varied considerably between samples and patients ( Fig. 6; Supplementary Tables S4-6 ). Overall, the top 25 bacterial species by average abundance accounted for more than 85% of the total abundance of bacterial species, and in the case of samples from the palatal mucosa of DS patients, accounted for 98% of the overall abundance.
Hundreds of unique bacterial species were detected in each of the samples. Many species were unique to either DS or NoDS patients and may contribute to the incidence of DS. However, of the bacterial species found in both DS and NoDS patients, some substantial differences in the relative abundance were detected (Fig. 6) .
In samples of the denture-fitting surfaces of NoDS patients (Fig. 6A) , the relative proportions of Acinetobacter johnsonii and Streptococcus mitis were nearly three-fold higher compared with DS patients, and proportions of Actinomyces odontolyticus were nearly six-fold higher. Additional differences were also observed, but to a lesser www.nature.com/scientificreports www.nature.com/scientificreports/ extent. These included a reduction in the presence of Pseudomonas putida, A. lwoffii, Lactobacillus salivarius and a slight decrease in A. lingnae in samples from NoDS patients. Furthermore, two of the three most abundant bacterial species in samples of the fitting surface of the denture were unique to the DS group. These included an unknown species within the genus Myroides, and Pseudomonas fluorescens, with relative abundances of approximately 8.5% and 7.2%, respectively. The presence of Myroides was not detected at any other sample site.
Further differences were observed for microbiota of the palatal mucosa (Fig. 6B) . Pseudomonas fluorescens was the bacterial species with highest representation in DS patients, but was also detected in NoDS patients. There was, however, a substantial difference in the average relative abundance, with a decrease from 19.99% in DS patients to 2.34% in NoDS patients. This was the largest difference for all bacterial species, irrespective of sample site. Furthermore, a greater than six-fold increase in the proportion of Brevundimonas vesicularis in NoDS patients compared with DS patients was evident. Conversely, a reduction of S. oralis, Chrysobacterium spp., B. terrae and a slight decrease in A. johnsonii were observed in NoDS patients. As was also evident in samples of the fitting surface of dentures, a number of unique bacterial species were detected in the DS and NoDS groups.
Streptococcus salivarius was detected at the highest relative abundance from tongue samples (Fig. 6C) . A small reduction was observed between DS and NoDS patients of approximately 3% (DS = 18.41%, NoDS = 15.37%), but the abundances were still higher than all other bacteria detected in either the tongue samples of DS or NoDS patients. Large differences were observed in the proportion of P. fluorescens between DS (12.48%) and NoDS (2.06%), and S. mitis (DS = 6.09%, NoDS = 11.18%). Smaller differences were observed with other bacterial species common between DS and NoDS patients, but their proportional contribution to the microbiota was approximately 2% or less, thus the extent of the differences were less clear.
When patients were sub-grouped by smoking status, some clear differences in OTU relative abundances were evident. Strong similarities in the numbers of OTUs detected from samples of the denture-fitting surface were evident between smokers and non-smokers, irrespective of DS state (Fig. 7A) . In samples from biotic sites (Fig. 7B,C) , however, smokers with DS had a much reduced quantity of OTUs detected than all other groups, significantly (P < 0.05 vs non-smokers with DS and non-smokers without DS, and P < 0.01 versus smokers with DS) so in samples from the tongue (Fig. 7C) .
Discussion
This research represents the first clinical study using next generation sequencing to characterise denture-associated biofilms from patients with and without clinical presentation of DS, with a specific aim of characterisation to species level to associate presence/absence and abundance with incidence of disease. Previous studies have evaluated DS associated microbiota, but the data were only analysed to genus level 25, 26 . Campos et al., (2008) completed a similar study to the one reported here, using pooled swab samples of DS versus NoDS patient groups, but also only reported data at genus level 27 . Genus-level information is important, but it is also well documented that considerable differences exist between species of the same genera. In the oral context, S. salivarius and S. mutans are good examples of distinct species within the same genus, particularly in terms of virulence and pathogenicity. Streptococcus salivarius is considered a commensal bacterial species, not normally associated with oral infection, whereas S. mutans is a known pathogen, associated with the development of dental caries. Furthermore, a study by Kim et al., (2017) demonstrated inter-kingdom interactions between S. mutans and C. albicans, where the presence of C. albicans resulted in an increase in the formation of microcolonies and subsequent virulence of S. mutans 28 . Therefore, an increase in proportion and virulence of a particular bacterial species may lead to a worse overall prognosis, and needs to be considered within the wider context of the microbiota. www.nature.com/scientificreports www.nature.com/scientificreports/ NGS data did not show any significant (P > 0.05) differences in the overall bacterial microbiota between patients with or without DS for the denture-fitting surface, or palatal mucosa. Indeed, the results for these samples were similar for both the number of unique species detected (Chao index), and in the richness and evenness of spread (Shannon index). However, in samples from the tongue, a significant (P = 0.007) decrease was observed in the number of unique bacteria species in patients with DS, compared to those without DS. This is interesting because a reduction in biodiversity, resulting in a state of dysbiosis, can lead to development of more extreme local environments where microorganisms with more extreme tolerances can thrive. Such changes in environmental conditions have been observed in the lung and the gut, and as a result of these changes, the onset of dysbiosis occurs, leading to an exacerbation of susceptibility to infections and a reduction in function particularly in the strictly-managed environment of the lung 29, 30 . Subsequently, the behaviour of these microorganisms, and www.nature.com/scientificreports www.nature.com/scientificreports/ the way they utilise nutrients and contribute to the local environmental conditions can further damage the local environment, such as the host 31, 32 . When analysing individual bacterial species, some clear and clinically interesting differences were evident. The abundance of individual bacterial species within sample groups revealed some notable differences. For example, in samples from the denture-fitting surface, a bacterial species within the genus Myroides (species unknown) was found exclusively in the DS sample group (at approximately 8.5% relative abundance). Myroides (specifically the species M. odoratimimus) have been implicated in soft tissue infections of immunocompetent patients 33 , and linked with cases of bacteraemia in diabetic patients 34 , which is also a risk-factor for DS. It is therefore possible that this microorganism in the DS group could contribute to palatal inflammation. Alternatively, the presence of bacteria could also contribute to the local microbial community (biofilms) residing on the denture surface, and the modulation of Candida virulence, thus indirectly promoting palatal inflammation.
Pseudomonas fluorescens was detected exclusively in the denture samples from DS patients with an abundance of approximately 7%. This species was however also detected in both DS and NoDS samples of the palate and tongue, indicating its presence was not necessarily by chance, but it had successfully colonised each of these sites. There were notable differences in the abundance of P. fluorescens between DS and NoDS from palate (DS = 20%, NoDS = 2.3%) and tongue (DS = 12.5%, NoDS = 2%) samples. At both biotic sites (palate and tongue), there was therefore a basal level of P. fluorescens presence of approximately 2% of the overall bacterial microbiota. It is unclear whether the change in the abundance was caused by DS, or that it was responsible for the onset of DS. DS is a very complex infection with many influencing factors, where no apparent single factor contributes solely to the incidence or development of the disease. www.nature.com/scientificreports www.nature.com/scientificreports/ In anticipation of future clinical studies, it would be of interest to obtain additional clinical information of each patient, beyond the smoking status and demographic details. Information such as presence of diabetes, HIV status, diet, previous episodes of oral candidosis, denture state (e.g. age of denture, physical condition, cleaning regime), and dental health (including number of remaining teeth and oral hygiene regime) could have been assessed. Each of these may influence the conditions in the mouth, and thus, the resident microbiota. Poor glycaemic control due to diabetes has been associated with increased susceptibility to DS, as have HIV infection, smoking and poor oral hygiene, and with this limited sample set, although it would have been difficult to make statistically valid associations, an indication of trends may have provided foundation for additional studies to evaluate these parameters.
The sample collection, extraction and utilisation of DNA provided detailed information of what bacteria were present, but not necessarily whether they were viable or metabolically active. This is an interesting area to consider, as the mere physical presence of microorganisms, irrespective of viability can elicit an immune response to the physical cell surface components such as mannans and β-d-(1,3)-glucans of Candida 35, 36 , and lipopolysaccharide or peptidoglycan of Gram-negative and Gram-positive bacterial cells respectively 36, 37 . Viable bacteria, particularly pathogens, will arguably lead to a worse prognosis without intervention, but follow up studies would be required, and it would be of scientific value to establish a baseline microbiota, then monitor changes with incidence of disease.
Conclusions
Although differences in the overall bacterial microbiota between sample sites were evident, considerable differences between DS and non-DS patients were observed for microbiota of the tongue. The tongue is an important reservoir of microorganisms for the oral cavity and the oropharynx, and is known to harbour many anaerobic microorganisms. The reduction in biodiversity demonstrated in patients with DS suggested that dysbiosis may contribute to the onset of disease/infection, whereby the relative influence of bacterial species of higher Figure 7 . Box and whisker lot showing Chao index analysis, with samples grouped by sample site, DS state and sub-grouped by smoking status. A significant reduction was observed in smokers with DS relative to nonsmokers with DS and non-smokers without DS (P < 0.05) and smokers without DS (P < 0.01) in samples of the tongue, but no significant differences were observed in samples of the denture-fitting surface. Samples of the palate showed a similar trend to that of the tongue, but with no statistical significance. (2019) 9:10228 | https://doi.org/10.1038/s41598-019-46494-0 www.nature.com/scientificreports www.nature.com/scientificreports/ abundance within the community is further enhanced. These findings, taken together with our previous research documenting the bacterial modulation of Candida virulence, support the need for further exploration of the bacterial microbiota associated with DS and the importance of characterisation of complex communities to species level. patient recruitment and sample collection. In order to achieve a robust consistency between recruited individuals, strict criteria were used to exclude factors that are known to substantially impact the oral microbiome. Patients were required to be over the age of 18 years, able and willing to consent, and have a complete upper acrylic denture. Patients who had received antibiotics or antifungal drugs, used steroids (systemic or inhaler), immunosuppressant or investigational drugs, or participated in another clinical study in the 30 days prior to recruitment, were not eligible for recruitment to the study.
Materials and
The clinical information recorded for each patient included: gender, age, smoking status, and the presence and extent of denture stomatitis according to Newton's classification.
Clinical sampling. Samples were obtained by clinically qualified and trained dental professionals employed by the Cardiff University School of Dentistry. The dental professionals worked under the guidelines and regulation of the General Dental Council, and sampling performed according to best practices.
Prior to any clinical intervention, the fitting-surface of the denture, the tongue and the hard palate were sampled using separate sterile Transwab ® Amies Charcoal swabs (Medical Wire and Equipment, Wiltshire, UK),
where the swabs were rubbed across each site for 15 s. Additionally, for detection and isolation of Candida, individual 2 cm 2 sterile foam squares pre-soaked in phosphate buffered saline solution (PBS) were pressed against the denture fitting surface, tongue and hard palate for 30 s. The squares were then placed directly onto a Sabouraud dextrose agar (SDA) plate in the clinic prior to immediate transfer to the laboratory for aerobic incubation for 24-48 h at 37 °C. Random representative colonies considered typical for Candida were subcultured onto CHROMagar ® Candida (BD Biosciences, Oxford, UK), and incubated for a further 48 h.
Laboratory processing of swab samples. Prior to collection of clinical samples, validation of the sampling process involving testing charcoal swabs was performed. Swabs of in vitro biofilms cultured using Streptococcus sanguinis NCTC 7863 and Candida albicans ATCC 90028 were collected, and the DNA extracted using the 'Gram-positive bacteria' extraction protocol of the Gentra PureGene Bact/Yeast DNA extraction kit (Qiagen, USA) as detailed by the manufacturer. The extracted and purified DNA was then subjected to endpoint PCR amplification. Positive amplification was observed confirming the suitability of the method. The relative level of microorganisms within clinical samples was anticipated to be less than would be observed in in vitro biofilms, therefore nested-PCR for detection of Candida species was incorporated to enhance sensitivity of detection.
Under aseptic conditions, the swab tip was carefully separated from the stem and placed into a sterile bijou container containing 1 ml of PBS, then vortex mixed at 2,500 rev/min for 1 min. The supernatant was collected, thoroughly mixed and transferred to a sterile microcentrifuge tube and centrifuged for 2 min at 13,000 × g. The supernatant was discarded and 300 μL of sterile PBS added. The suspension was then homogenised by pipetting. Aliquots of the suspension were prepared for DNA extraction for bacterial and fungal molecular analyses.
Total microbial DNA extraction from clinical swab samples. Total bacterial DNA was extracted using the Gentra PureGene Bact/Yeast DNA extraction kit (Qiagen, USA) according to the Gram-positive bacteria extraction protocol provided by the manufacturer. Extracted DNA was stored at −20 °C prior to next generation sequencing.
In addition to culture, Candida presence was established by nested PCR. A portion of the swab sample was used for extraction of yeast DNA using the Gentra PureGene Bacteria/Yeast DNA extraction kit, according to the yeast/fungi extraction protocol.
Identification of Candida from clinical samples by nested PCR. Extracted fungal DNA was pre-amplified using a general nested PCR and the RenDX Fungiplex Amplification Kit (Renishaw Diagnostics Ltd, Glasgow, UK) in a final reaction volume of 50 μL. The method targets the region spanning positions 620-760 on the fungal 18S rRNA gene. Each reaction mix contained 5 μL of 10 × PCR buffer, 1 μL MgCl 2 , 4 μL dNTPs, 10 μL primer mix (final concentration 600 mM), 19.5 μL molecular grade water, 0.5 μL (2.5 U) Taq polymerase and 10 μL of the extracted DNA template. Target DNA was amplified using the following thermal cycling protocol: 95 °C for 15 min, followed by 45 cycles of 94 °C for 30 s, 58 °C for 30 s and 72 °C for 30 s. A final elongation step of 72 °C for 7 min was performed. Samples were held at 4 °C until required for the next stage of amplification.
Amplified samples were subjected to a second round of probe-based real-time PCR to amplify 18S ribosomal RNA (18S rRNA) sequences specific to pan Candida species, C. krusei and C. glabrata. The primers used are detailed in Supplementary Table S7. DNA samples were amplified in the second round using LightCycler FastStart DNA Master HybProbe (Roche Diagnostics, Sussex, UK), and reactions contained 2.5 μL of hybridisation mix, 3 μL of MgCl 2 , 15 μL of nuclease free molecular biology grade water, 2.5 μL of primer/probe mix and 2 μL of template DNA. The preparations were
